|Bid||204.97 x 800|
|Ask||270.02 x 800|
|Day's range||208.20 - 211.54|
|52-week range||189.40 - 301.34|
|Beta (5Y monthly)||0.45|
|PE ratio (TTM)||39.91|
|Forward dividend & yield||1.68 (0.79%)|
|Ex-dividend date||11 May 2022|
|1y target est||N/A|
Every investor in ResMed Inc. ( NYSE:RMD ) should be aware of the most powerful shareholder groups. Large companies...
ResMed's (RMD) acquisition of a renowned out-of-hospital software solutions company is expected to strengthen its SaaS business.
(Bloomberg) -- ResMed Inc., a publicly traded medical equipment provider, will buy MediFox Dan Holding GmbH, a German health software company owned by private equity firm Hg.Most Read from BloombergChina Alarms US With Private Warnings to Avoid Taiwan StraitStocks’ Pandemic Bull Run Ends With Recession Fear: Markets WrapCrypto Market Sinks Below $1 Trillion After Latest DeFi BlowupVolatility Grips Stocks as Traders Brace for Fed: Markets WrapBitcoin Turns Lower Again as Celsius Weighs on Sentime